The weekly litigation news digest is live. Subscribe now

IP Verse

Methods Of Administering Fluvoxamine Therapy - EP2653162

The patent EP2653162 was granted to Intermune on May 20, 2020. The application was filed on Dec 3, 2010 under application number EP13176914A. The patent is currently recorded with a legal status of "Revoked".

EP2653162

INTERMUNE
Application Number
EP13176914A
Filing Date
Dec 3, 2010
Status
Revoked
Jun 16, 2023
Publication Date
May 20, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ALFRED E TIEFENBACHERFeb 19, 2021HAMM & WITTKOPPWITHDRAWN
INTAS PHARMACEUTICALSFeb 19, 2021ACCORD HEALTHCAREWITHDRAWN
AERAFeb 16, 2021AERAWITHDRAWN
SANDOZFeb 10, 2021ELKINGTON AND FIFEWITHDRAWN

Patent Citations (2) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONEP2324831
OTHEREP2324831

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents